|
流感病毒传染性A/维多利亚/4897/2022[H1N1]22/316
|
EA
|
22/316
|
咨询
|
1-4/12周
|
|
抗肺炎球菌血清型17F单克隆抗体[克隆17-120AE4IE3IG2]22/304
|
EA
|
22/304
|
2883
|
1-4/12周
|
|
流感病毒传染性IVR-238[A/Victoria/4897/2022[H1N1]22/318
|
EA
|
22/318
|
咨询
|
1-4/12周
|
|
抗肺炎球菌血清型8单克隆抗体[克隆6G1]22/292
|
EA
|
22/292
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型11A单克隆抗体[克隆2E2]22/296
|
EA
|
22/296
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型12F单克隆抗体[克隆1C8]22/298
|
EA
|
22/298
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型15A-B单克隆抗体[克隆1B4]22/300
|
EA
|
22/300
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型10A单克隆抗体[克隆17-117DE8IIE9]22/294
|
EA
|
22/294
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型16F单克隆抗体[克隆20-121EC11IIF10VE2]22/302
|
EA
|
22/302
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型23F单克隆抗体[克隆15-113HA5IE2IE2]22/280
|
EA
|
22/280
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型15B单克隆抗体[克隆2F4]22/278
|
EA
|
22/278
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型5单克隆抗体[克隆1366KG3IA11]22/288
|
EA
|
22/288
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型CPS单克隆抗体[克隆14-108BA5IE10]22/284
|
EA
|
22/284
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型24F单克隆抗体[克隆2F2]22/282
|
EA
|
22/282
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型4单克隆抗体[克隆14-100JA2IIE72G6]22/286
|
EA
|
22/286
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型6B单克隆抗体[克隆14-102CC2ID9]22/290
|
EA
|
22/290
|
2883
|
1-4/12周
|
|
第1批英夫利昔单抗抗药物抗体国际参考盘22/272
|
EA
|
22/272
|
10203
|
1-4/12周
|
|
流感病毒传染性SAN-015[A/Lyon/820/2021][H1N1]22/268
|
EA
|
22/268
|
咨询
|
1-4/12周
|
|
流感病毒传染性IVR-215[A/Victoria/2570/2019][H1N1]22/274
|
EA
|
22/274
|
咨询
|
1-4/12周
|
|
抗肺炎球菌血清型35B单克隆抗体[克隆3F6]22/266
|
EA
|
22/266
|
2883
|
1-4/12周
|